-
Uncategorized2 months agoSTAT+: HaloMD’s legal win highlights the difficulty of challenging arbitration decisions
Arbitration decisions, it turns out, are like cockroaches. They’re very hard to kill. It’s a long held truism in the legal world, and it was underscored...
-
Uncategorized2 months agoTrump taps former public health leader Erica Schwartz to run CDC
President Trump nominated Erica Schwartz on Thursday to be director of the Centers for Disease Control and Prevention, tapping a former public health leader for a...
-
Uncategorized2 months ago
RFK Jr. defends FDA, Makary following Republican questions
RFK Jr. defends FDA, Makary following Republican questions
-
Uncategorized2 months ago
Intercellular Communication via Condensate Corona-Nanoparticle Complexes
Cells and tissues have a multitude of methods for intercellular communication. Nanoscale assemblies that transfer proteins and RNAs between cells are known, but the impacts of...
-
Uncategorized2 months agoSTAT+: Kennedy focuses on affordability, combating fraud in Capitol Hill hearing
WASHINGTON — Health Secretary Robert F. Kennedy Jr. returned to Capitol Hill Thursday, where he defended the administration’s efforts to fight health care fraud and improve...
-
Uncategorized2 months ago
Proteins.1 Launches to Develop Single Molecule Protein Amplification Tech for Diagnostics
Finnish deep-tech startup, Proteins.1, launched with €4.7 million in pre-seed funding, led by Lifeline Ventures and Cloudberry Ventures, with in-kind support from VTT and Business Finland....
-
Uncategorized2 months ago
Drug pricing watchdog calls for increased transparency into FDA’s accelerated approval decisions
Drug pricing watchdog calls for increased transparency into FDA’s accelerated approval decisions
-
Uncategorized2 months ago
AACR 2026 Chairs Identify Themes and Highlights from the Conference
The American Association for Cancer Research (AACR) Annual Meeting kicks off this weekend in San Diego. A whirlwind of sessions, keynotes, fireside chats, posters, and exhibitors,...
-
Uncategorized2 months ago
FDA mulls compounding for peptides previously flagged over safety risks
With Health Secretary Robert F. Kennedy Jr. declaring himself “a big fan of peptides,” the FDA has arranged an advisory committee to discuss allowing compounders to...
-
Uncategorized2 months agoSTAT+: Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target
The scientists whose work spurred the development of powerful obesity drugs like Eli Lilly’s Zepbound are now raising a provocative hypothesis: Perhaps targeting the GLP-1 hormone...
Amgen shores up Tavneos’ FDA defense with Duke data analysis
